Skip to content

Author

Xiaofei Lu

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access 2026

METTL16 promotes PD-L1 expression and mediates immunosuppression in B-cell lymphomas via m6A methylation.

OBJECTIVES Immune Checkpoint Inhibitors (ICIs) have changed cancer treatment. Altered expression of methyltransferase-like 16 (METTL16), one of the initial m6A "writers", is associated with malignant progression. METTL16 is a methyltransferase that may influence the treatment response of B-cell lymphoma (BCL). METHOD...

Yan Chen, Sen Cao, Xiaofei Lu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.